These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1828433)

  • 1. Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina.
    Mosinger JL; Price MT; Bai HY; Xiao H; Wozniak DF; Olney JW
    Exp Neurol; 1991 Jul; 113(1):10-7. PubMed ID: 1828433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excitotoxic neurodegeneration induced by deprivation of oxygen and glucose in isolated retina.
    Romano C; Price MT; Almli T; Olney JW
    Invest Ophthalmol Vis Sci; 1998 Feb; 39(2):416-23. PubMed ID: 9478002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural and biochemical studies on the neuroprotective effects of excitatory amino acid antagonists in the ischemic rat retina.
    Matini P; Moroni F; Lombardi G; Faussone-Pellegrini MS; Moroni F
    Exp Neurol; 1997 Aug; 146(2):419-34. PubMed ID: 9270053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of excitatory amino acids in neuropathology].
    Wikinski SI; Acosta GB
    Medicina (B Aires); 1995; 55(4):355-65. PubMed ID: 8728878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous blockade of non-NMDA ionotropic receptors and NMDA receptor-associated ionophore partially protects hippocampal slices from protein synthesis impairment due to simulated ischemia.
    Virgili M; Contestabile A; Barnabei O
    Hippocampus; 1995; 5(1):91-7. PubMed ID: 7787950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
    Massieu L; Thedinga KH; McVey M; Fagg GE
    Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective use of N-methyl-D-aspartate receptor antagonists as a spinoplegia against excitatory amino acid neurotoxicity.
    Cho Y; Ueda T; Mori A; Shimizu H; Haga Y; Yozu R
    J Vasc Surg; 2005 Oct; 42(4):765-71. PubMed ID: 16242566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to kynurenic acid of the NMDA receptor-dependent toxicity of 3-nitropropionic acid and cyanide in cerebellar granule neurons.
    Fatokun AA; Smith RA; Stone TW
    Brain Res; 2008 Jun; 1215():200-7. PubMed ID: 18486115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of two novel N-methyl-D-aspartate antagonists: EAA-090 (2-[8,9-dioxo-2,6-diazabicyclo [5.2.0]non-1(7)-en2-yl]ethylphosphonic acid) and EAB-318 (R-alpha-amino-5-chloro-1-(phosphonomethyl)-1H-benzimidazole-2-propanoic acid hydrochloride).
    Sun L; Chiu D; Kowal D; Simon R; Smeyne M; Zukin RS; Olney J; Baudy R; Lin S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):563-70. PubMed ID: 15075380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of NMDA receptor glycine site antagonists on hypoxia-induced neurodegeneration of rat cortical cell cultures.
    Priestley T; Horne AL; McKernan RM; Kemp JA
    Brain Res; 1990 Oct; 531(1-2):183-8. PubMed ID: 2149665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycine site NMDA receptor antagonists provide protection against ischemia-induced neuronal damage in hippocampal slice cultures.
    Newell DW; Barth A; Malouf AT
    Brain Res; 1995 Mar; 675(1-2):38-44. PubMed ID: 7796152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury?
    Prehn JH; Lippert K; Krieglstein J
    Eur J Pharmacol; 1995 Jan; 292(2):179-89. PubMed ID: 7720791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal ketamine promotes neuroprotection in rat eyes after experimental ischemia.
    Dourado LFN; Oliveira LG; da Silva CN; Toledo CR; Fialho SL; Jorge R; Silva-Cunha A
    Biomed Pharmacother; 2021 Jan; 133():110948. PubMed ID: 33249278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential action of NMDA antagonists on cholinergic neurotoxicity produced by N-methyl-D-aspartate and quinolinic acid.
    Pawley AC; Flesher S; Boegman RJ; Beninger RJ; Jhamandas KH
    Br J Pharmacol; 1996 Mar; 117(6):1059-64. PubMed ID: 8882597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate receptor antagonists protect against ischemia-induced retinal damage.
    Lombardi G; Moroni F; Moroni F
    Eur J Pharmacol; 1994 Dec; 271(2-3):489-95. PubMed ID: 7705449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
    Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
    Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of a non-NMDA antagonist, GYKI 52466, increases excitotoxic Purkinje cell degeneration caused by ibogaine.
    O'Hearn E; Molliver ME
    Neuroscience; 2004; 127(2):373-83. PubMed ID: 15262328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of excitatory amino acid release by N-methyl-D-aspartate receptors in rat striatum: in vivo microdialysis studies.
    Bustos G; Abarca J; Forray MI; Gysling K; Bradberry CW; Roth RH
    Brain Res; 1992 Jul; 585(1-2):105-15. PubMed ID: 1355000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of non-NMDA receptors augments the neuroprotective effect of NMDA receptor blockade in cortical cultures subjected to prolonged deprivation of oxygen and glucose.
    Kaku DA; Goldberg MP; Choi DW
    Brain Res; 1991 Jul; 554(1-2):344-7. PubMed ID: 1681989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NBQX, a competitive non-NMDA receptor antagonist, reduces degeneration due to focal spinal cord ischemia.
    von Euler M; Seiger A; Holmberg L; Sundström E
    Exp Neurol; 1994 Sep; 129(1):163-8. PubMed ID: 7925838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.